ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Boston, MA, USA:

Vitamin D for COVID-19 Trial (VIVID)

The Vitamin D for COVID-19 Trial (VIVID) is a randomized, placebo-controlled clinical trial in 2024 men and women from across the U-...

Active, not recruiting
COVID-19
Dietary Supplement: vitamin D
Dietary Supplement: Placebo

Phase 3

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia....

Enrolling
Covid19
Drug: Defibrotide

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Boston, Massachusetts, United States and 123 other locations

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Boston, Massachusetts, United States and 106 other locations

The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-expo...

Active, not recruiting
Covid19
Drug: Placebo
Drug: RTB101

Phase 2

resTORbio

Roslindale, Massachusetts, United States and 1 other location

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

Burlington, Massachusetts, United States and 17 other locations

The coronavirus disease 2019 (COVID-19) global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) -...

Enrolling
COVID-19
Cardiovascular Diseases
Drug: Enoxaparin

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Boston, Massachusetts, United States and 217 other locations

. There are no established monitoring nationwide protocols for COVID-19 prevention of infection. Due to the lack of such protocols,-...

Enrolling
COVID-19 Respiratory Infection
Diagnostic Test: SARS CoV-2 antigen tests

Phase 1

IDX20

Chelsea, Massachusetts, United States

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 1

Pfizer
Pfizer

Boston, Massachusetts, United States and 32 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems